Impact of a Mobility Program
Impact of a Hospital Mobility Program on Function After Discharge
1 other identifier
interventional
132
1 country
2
Brief Summary
After hospitalization, many older adults experience more difficulty getting around in the community and performing one or more of their basic activities of daily living (ADLs) like bathing or dressing. The goals of this study are to test the effectiveness of a mobility intervention, compared to usual care, on change in mobility after hospitalization, to determine the impact on one-year outcomes such as nursing home placement and to identify which Veterans benefit the most from the intervention. Ultimately, the goal is to improve recovery after hospitalization and reduce disability in hospitalized Veterans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2016
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2016
CompletedFirst Posted
Study publicly available on registry
February 4, 2016
CompletedStudy Start
First participant enrolled
December 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedResults Posted
Study results publicly available
July 5, 2024
CompletedJuly 5, 2024
March 1, 2024
4.8 years
January 8, 2016
February 15, 2023
March 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Life-Space Assessment Score
The UAB Study of Aging Life-Space Assessment (LSA) is a validated tool that measures mobility and function based on the distance which a person reports moving during the four weeks preceding the assessment. The range in scores is 0-100 with higher scores representing better life space mobility.
One year
Secondary Outcomes (12)
Presence of Adverse Outcomes: Rehospitalization
One Year
Presence of Adverse Outcomes: Nursing Home Placement
One year
Presence of Adverse Outcomes: Death
One year
Activities of Daily Living (ADLs)
One Year
Presence of Adverse Outcomes (ED Visits, Rehospitalization, Nursing Home Placement, Death)
One year
- +7 more secondary outcomes
Study Arms (2)
Intensive
EXPERIMENTALMP patients will participate in a program of progressive walking and transfer training up to three times a day, seven days a week throughout the hospital stay.
Friendly visit
PLACEBO COMPARATORUC patients will receive three times a day "friendly visits", seven days a week by members of the research team to control for the daily attention that MP patients receive.
Interventions
MP patients will participate in a program of progressive walking and transfer training up to three times a day, seven days a week throughout the hospital stay. MP patients will begin with assisted sitting, then standing, progressing to weight shifting and stepping in place, and then to walking as tolerated. The level of mobility recommended to the MP patient by the Walker will be dependent on the individual patient and will incorporate the activities patients were deemed able to do independent of cueing or assistance during each walking session.
UC patients will receive three times a day "friendly visits", seven days a week by members of the research team to control for the daily attention that MP patients receive.
Eligibility Criteria
You may qualify if:
- Age 50 years admitted to one of the five hospital wards of the Birmingham VA Medical Center (VAMC) for any medical illness, e.g.:
- Pneumonia
- Heart failure
- Chronic obstructive pulmonary disease (COPD) exacerbation
- Or other medical (versus surgical) indication for hospitalization
- Patients will be recruited within 48 hours of hospitalization, followed throughout their hospitalization and for one year after hospital discharge.
You may not qualify if:
- Patients admitted for brief observation will be excluded, e.g.:
- hour observation for possible myocardial infarction
- Inability to walk across a small room 2 weeks prior to admission
- Inability to walk safely with assistance, based on a strength and balance screen (see Training of Walkers, below for details)
- Having a pulmonary embolus, unstable angina or other medical diagnosis deemed by the primary physician to be a contraindication to walking
- Being on hospice or comfort care
- Being in a semi-private room with another currently enrolled participant
- Non-English speaking, blind, or deaf
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Birmingham VA Medical Center, Birmingham, AL
Birmingham, Alabama, 35233, United States
UAB Hospital
Birmingham, Alabama, 35294, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Study recruitment did not meet the calculated sample size target of 258 participants.
Results Point of Contact
- Title
- Dr. Alayne Markland
- Organization
- Birmingham VA - GRECC Director; Professor at UAB
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia J Brown, MD MSPH
Birmingham VA Medical Center, Birmingham, AL
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 8, 2016
First Posted
February 4, 2016
Study Start
December 12, 2016
Primary Completion
September 30, 2021
Study Completion
September 30, 2021
Last Updated
July 5, 2024
Results First Posted
July 5, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
No detailed plans at this time.